Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer

Anticancer Research

Volumn 34, Issue 11, 2014, Pages 6397-6403

  Masuda, Takanobu ^a   Nakashima, Yuichiro ^a   Ando, Koji ^a   Yoshinaga, Keiji ^a   Saeki, Hiroshi ^a   Oki, Eiji ^a   Morita, Masaru ^a   Oda, Yoshinao ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CXCL12; Immunohistochemistry; Translocation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH CANCER; SUBMUCOSA; CANCER STAGING; CELL NUCLEUS; CYTOPLASM; ENZYME IMMUNOASSAY; FOLLOW UP; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; SECONDARY; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CHEMOKINE CXCL12; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; RECEPTORS, CXCR4; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84916229433     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T and Nagasawa T: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393(6685): 591-594, 1998.
2. Burger JA and Kipps TJ: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107(5): 1761-1767, 2006.
3. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W and Ratajczak J: The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20(11): 1915-1924, 2006.
4. Arya M, Patel HR and Williamson M: Chemokines: key players in cancer. Curr Med Res Opin 19(6): 557-564, 2003.
5. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824): 50-56, 2001.
6. Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R and Basik M: The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 97(3): 275-283, 2006.
7. Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A and Pfeffer U: CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 45(14): 2579-2587, 2009.
8. Woo SU, Bae JW, Kim CH, Lee JB and Koo BW: A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer. Ann Surg Oncol 15(1): 281-285, 2008.
9. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23(12): 2744-2753, 2005.
10. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R and Scala S: Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 12(9): 2795-2803, 2006.
11. Yoshitake N, Fukui H, Yamagishi H, Sekikawa A, Fujii S, Tomita S, Ichikawa K, Imura J, Hiraishi H and Fujimori T: Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98(10): 1682-1689, 2008.
12. Speetjens FM, Liefers GJ, Korbee CJ, Mesker WE, van de Velde CJ, van Vlierberghe RL, Morreau H, Tollenaar RA and Kuppen PJ: Nuclear localization of CXCR4 determines prognosis for colorectal cancer patients. Cancer Microenviron 2(1): 1-7, 2009.
13. Wang SC, Lin JK, Wang HS, Yang SH, Li AF and Chang SC: Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis 25(10): 1185-1191, 2010.
14. Na IK, Scheibenbogen C, Adam CStroux A, Ghadjar P, Thiel E, Keilholz U and Coupland SE: Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. Hum Pathol 39(12): 1751-1755, 2008.
15. Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, Rengifo T, Sica GL, Port JL, Lee PC, Paul S, Altorki NK and Saqi A: CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 137(3): 615-621, 2009.
16. Woo IS, Hong SH, Byun JH, Kang JH, Jeon HM and Choi MG: Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma. Cancer Invest 26(3): 256-261, 2008.
17. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O and Saiki I: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66(4): 2181-2187, 2006.
18. Ishigami S, Natsugoe S, Okumura H, Matsumoto M, Nakajo A, Uenosono Y, Arigami T, Uchikado Y, Setoyama T, Arima H, Hokita S and Aikou T: Clinical implication of CXCL12 expression in gastric cancer. Ann Surg Oncol 14(11): 3154-3158, 2007.
19. Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, Koike M, Fujiwara M, Yamamura Y and Nakao A: Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep 20(5): 1117-1123, 2008.
20. Shibuta K, Begum NA, Mori M, Shimoda K, Akiyoshi T and Barnard GF: Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and digestive tract cancer. Int J Cancer 73(5): 656-662, 1997.
21. Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S and Jo DY: Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol 34(2): 473-480, 2009.
22. Iwasa S, Yanagawa T, Fan J and Katoh R: Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res. 29(11): 4751-4758, 2009.
23. Kwak MK, Hur K, Park DJ, Lee HJ, Lee HS, Kim WH, Lee KU, Choe KJ and Yang HK: Expression of chemokine receptors in human gastric cancer. Tumour Biol 26(2): 65-70, 2005.
24. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 12th ed. Tokyo: Kanehara & Co., Ltd; 1993.
25. Murdoch C: CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175-184, 2000.
26. Signoret N, Rosenkilde MM, Klasse PJ, Schwartz TW, Malim MH, Hoxie JA and Marsh M: Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci 111(Pt 18): 2819-2830, 1998.
27. Wang L, Wang Z, Yang B, Yang Q, Wang L and Sun Y: CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma. Oncol Rep 22(6): 1333-1339, 2009.
28. Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5(5): R144-150, 2003.